Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pierre Legault Insider Profile
4 Followers
Pierre Legault, CEO, Director at NephroGenex, holds 65.00K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 33.50K shares in Bicycle Therapeutics (Ticker: BCYC), holds 0.00 shares in Urovant Sciences (Ticker: UROV).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-54.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Pierre Legault holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 16, 2021 - Mar 16, 2022
Return:-51.50%
The most profitable trade made by Pierre Legault
Pierre Legault's Trading History
NephroGenex
Nov 12, 2015
―
Uninformative Buy
―
$9.23K
Syndax Pharmaceuticals
Feb 09, 2024
Director
Uninformative Buy
―
$1.36M
Armo Biosciences Inc
―
―
―
―
Urovant Sciences
Mar 31, 2021
―
Uninformative Sell
―
$0.00
Bicycle Therapeutics
Jan 04, 2024
Director
Uninformative Buy
―
$759.78K
NPS Pharma
―
―
―
―
Tobira Therapeutics
―
―
―
$0.00
Rite Aid
―
SEVP
―
$24.78K
Cyclacel Pharmaceuticals
―
Director
―
$0.00
Forest Labs
Jul 02, 2014
―
Uninformative Sell
―
―
List of latest transactions for each holding click on a transaction to see Pierre Legault's performance on stock
You May Also Like
Pierre Legault insider profile FAQ
What is the percentage of profitable transactions made by Pierre Legault?
The percentage of profitable transactions made by Pierre Legault is 0%.
What is the average return per transaction made by Pierre Legault?
The average return per transaction made by Pierre Legault is -54.90%.
What stocks does Pierre Legault hold?
Pierre Legault holds: NRXGQ, SNDX, ARMO, UROV, BCYC, NPSP, TBRA, RADCQ, CYCC, ~FRX stocks.
What was Pierre Legault’s latest transaction?
Pierre Legault latest transaction was an Uninformative Buy of ―.
What was Pierre Legault's most profitable transaction?
Pierre Legault’s most profitable transaction was an Informative Sell of BCYC stock on March 16, 2021. The return on the trade was -51.50%.
What is Pierre Legault's role in NephroGenex?
Pierre Legault's role in NephroGenex is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.